secwatch.observer — SEC 8-K summary
======================================

Issuer:     agilon health, inc. (AGL)
CIK:        0001831097
Form:       8-K
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0001628280-24-000516
Event type: earnings
Sentiment:  negative
Materiality: 0.90
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

agilon health cuts 2023 medical margin guidance by ~$110M; withdraws 2026 outlook
--------------------------------------------------------------------------------

- 2023 medical margin guidance lowered to $340M-$360M from $455M-$470M, a ~$110M reduction.
- 2023 Adjusted EBITDA guidance revised to loss of $55M-$69M from prior profit of $6M-$18M.
- Higher-than-expected medical costs from specialist visits, Part B drugs, outpatient surgeries cited.
- Initial 2024 outlook: medical margin $560M-$600M; Adjusted EBITDA $40M-$60M.
- Withdraws previously issued 2026 target; actions underway to improve predictability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831097/000162828024000516/0001628280-24-000516-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831097/000162828024000516/agl-20240105.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-000516

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer